Year |
Citation |
Score |
2020 |
Voynow JA, Fisher K, Sunday ME, Cotten CM, Hamvas A, Hendricks-Muñoz KD, Poindexter BB, Pryhuber GS, Ren CL, Ryan RM, Sharp JK, Young SP, Zhang H, Greenberg RG, Herring AH, et al. Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease. Pediatric Pulmonology. PMID 31995668 DOI: 10.1002/Ppul.24665 |
0.303 |
|
2015 |
Kay DM, Langfelder-Schwind E, DeCelie-Germana J, Sharp JK, Maloney B, Tavakoli NP, Saavedra-Matiz CA, Krein LM, Caggana M, Kier C. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening. Pediatric Pulmonology. 50: 771-80. PMID 26098992 DOI: 10.1002/ppul.23222 |
0.412 |
|
2010 |
Rock MJ, Sharp JK. Cystic fibrosis and CRMS screening: what the primary care pediatrician should know. Pediatric Annals. 39: 759-68. PMID 21162484 DOI: 10.3928/00485713-20101117-06 |
0.341 |
|
2009 |
Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. The Journal of Pediatrics. 155: S106-16. PMID 19914443 DOI: 10.1016/J.Jpeds.2009.09.003 |
0.38 |
|
2008 |
Sharp JK, Rock MJ. Newborn screening for cystic fibrosis. Clinical Reviews in Allergy & Immunology. 35: 107-15. PMID 18821063 DOI: 10.1007/S12016-008-8082-1 |
0.42 |
|
2002 |
Sharp JK. Monitoring early inflammation in CF. Infant pulmonary function testing. Clinical Reviews in Allergy & Immunology. 23: 59-76. PMID 12162107 DOI: 10.1385/CRIAI:23:1:059 |
0.372 |
|
Show low-probability matches. |